AMPOSVY
Swiss trademark · 848277 · Word mark · In force
Register entry
- Registration number
- 848277
- Application number
- 04761/2026
- Status
- In force
- Type
- Word mark
- Filed
- Mar 17, 2026
- Registered
- May 7, 2026
- Published
- May 7, 2026
- Protected until
- Mar 17, 2036
- Source
- Swissreg
Goods and services
Pharmaceuticals
Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of affective disorders; pharmaceutical preparations for the treatment of depressive disorders; pharmaceutical preparations for the treatment of anhedonia; pharmaceutical preparations for the treatment of major depressive disorder (MDD); pharmaceutical preparations for adjunctive treatment of major depressive disorder; pharmaceutical preparations for the treatment of bipolar disorders, post-traumatic stress disorders (PTSD) and attention deficit/hyperactivity disorders (ADHD); pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of disorders of the central nervous system
As filed
Pharmazeutische Präparate für den Menschen; pharmazeutische Präparate zur Behandlung psychiatrischer Störungen; pharmazeutische Präparate zur Behandlung von affektiven Störungen; pharmazeutische Präparate zur Behandlung von depressiven Störungen; pharmazeutische Präparate zur Behandlung von Anhedonie; pharmazeutische Präparate zur Behandlung von schwerer depressiver Störung (MDD); pharmazeutische Präparate zur Begleitbehandlung schwerer depressiver Störung; pharmazeutische Präparate zur Behandlung von bipolaren Störungen, posttraumatischen Belastungsstörungen (PTBS) und Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen (ADHS); pharmazeutische Präparate zur Behandlung neurologischer Erkrankungen; pharmazeutische Präparate zur Behandlung von Störungen des zentralen Nervensystems.
Science, technology and IT
Pharmaceutical research and development; medical and scientific research in the field of major depressive disorder; medical and scientific research in the field of psychiatric, affective and neurological disorders and disorders of the central nervous system; Provision of medical and scientific information in the field of pharmaceutical research and development
As filed
Pharmazeutische Forschung und Entwicklung; medizinische und wissenschaftliche Forschung auf dem Gebiet der schweren depressiven Störung; medizinische und wissenschaftliche Forschung auf dem Gebiet der psychiatrischen, affektiven, neurologischen Störungen und Störungen des Zentralnervensystems; Bereitstellung medizinischer und wissenschaftlicher Informationen im Bereich der pharmazeutischen Forschung und Entwicklung.
Medical, beauty and agricultural services
Provision of medical information; Providing medical information on the treatment of major depressive disorder; Providing medical information on the treatment of psychiatric, affective and neurological disorders and disorders of the central nervous system
As filed
Bereitstellung medizinischer Informationen; Bereitstellung medizinischer Informationen zur Behandlung von schwerer depressiver Störung; Bereitstellung medizinischer Informationen zur Behandlung von psychiatrischen, affektiven, neurologischen Störungen und Störungen des Zentralnervensystems.
Translated automatically. Only the text as filed is legally binding.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 28, 2026
Holder’s address changed
- Owner
- Neurocrine Switzerland GmbH, c/o TRETOR AG, Industriestrasse 7, 4410 Liestal → Neurocrine Switzerland GmbH, Hegenheimermattweg 167a, 4123 Allschwil
Published in Swissreg on 28.05.2026
- May 7, 2026
Registered
Published in Swissreg on 07.05.2026
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.